Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block for Analgesia in TAVI
NCT05904912Completed
- Sponsor
- Istanbul Medipol University
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: The need for fentanyl during the procedure. Started Jun 2023; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05904912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05904912.